American Express Company (AXP) – March’s Dividend Growth Model Portfolio – ValueWalk Premium
American Express Company (AXP)

American Express Company (AXP) – March’s Dividend Growth Model Portfolio

This report highlights last month’s top performers and features a stock from the current portfolio. March’s Dividend Growth Stocks Model Portfolio was made available to members on March 28, 2018.

Get Our Activist Investing Case Study!

Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!

We respect your email privacy

See 2017 Hedge Fund Letters.

Recap from February’s Picks

Our Dividend Growth Stocks Model Portfolio outperformed the S&P 500 on a price return basis and performed in line on a total return basis last month. The Model Portfolio fell 2.1% on a price return basis and fell 2.0% on a total return basis. The S&P 500 fell 2.4% on a price return basis and fell 2.0% on a total return basis. The portfolio’s best performing stock was Nu Skin Enterprises (NUS), which was up 5%. Overall, 16 out of the 30 Dividend Growth Stocks outperformed the S&P last month, and eight had positive returns.

The long-term success of our model portfolio strategies highlights the value of our Robo-Analyst technology[1], which scales our forensic accounting expertise (featured in Barron’s) across thousands of stocks[2].

The methodology for this model portfolio mimics an All-Cap Blend style with a focus on dividend growth. Selected stocks earn an Attractive or Very Attractive rating, generate positive free cash flow (FCF) and economic earnings, offer a current dividend yield >1%, and have a 5+ year track record of consecutive dividend growth. This model portfolio is designed for investors who are more focused on long-term capital appreciation than current income, but still appreciate the power of dividends, especially growing dividends.

Featured Stock from March: American Express Company (AXP: $93/share)

Credit card provider American Express Company (AXP) is the featured stock from March’s Dividend Growth Stocks Model Portfolio. AXP was first featured in our January 2016 case study on how return on invested capital (ROIC) impacts stock valuation. Since then, the stock is up 52% while the S&P 500 is up 27%. Despite this outperformance, AXP remains undervalued.

Since 2010, AXP’s revenue has grown 2% compounded annually while its after-tax profit (NOPAT) has grown 18% compounded annually. AXP’s NOPAT margin has improved from 6% in 2010 to 16% in 2017 while its return on invested capital (ROIC) improved from 6% to 14%.

Figure 1: AXP Revenue & NOPAT Since 2010

American Express Company (AXP)

Sources: New Constructs, LLC and company filings

Steady Dividend Growth Supported by FCF

AXP has increased its annual dividend for six consecutive years. The current annualized dividend has grown from $0.89/share in 2013 to $1.34/share in 2017, or 11% compounded annually. Positive FCF has fueled dividend growth in the past and should continue to do so in the future. From 2013-2017, AXP generated cumulative FCF of $25.6 billion (32% of market cap) and paid out cumulative dividends of $5.6 billion.

Companies with FCF well in excess of dividend payments provide higher quality dividend growth opportunities because we know the firm generates the cash to support the current dividend as well as a higher dividend. On the flip side, the dividend growth trajectory of a company where FCF falls short of the dividend payment over time cannot be trusted to grow or sustain its dividend because of inadequate free cash flow.

Figure 2: Free Cash Flow (FCF) vs. Regular Dividend Payments

Sources: New Constructs, LLC and company filings

AXP Remains Undervalued

At its current price of $93/share, AXP has a price-to-economic book value (PEBV) ratio of 0.9. This ratio means the market expects AXP’s NOPAT to permanently decline by 10%. This expectation seems overly pessimistic for a firm that has grown NOPAT by 6% compounded annually since 1998 and 18% compounded annually since 2010.

If AXP can maintain 2017 NOPAT margins (16%) and grow NOPAT by 3% compounded annually over the next decade, the stock is worth $127/share today – a 47% upside. Add in American Express’ 1.5% dividend yield and history of dividend growth, and it’s clear why this stock is in March’s Dividend Growth Stocks Model Portfolio.

Auditable Impact of Footnotes & Forensic Accounting Adjustments

Our Robo-Analyst technology enables us to perform forensic accounting with scale and provide the research needed to fulfill fiduciary duties. In order to derive the true recurring cash flows, an accurate invested capital, and a real shareholder value, we made the following adjustments to American Express’ 2017 10-K:

Income Statement: we made $3 billion of adjustments with a net effect of removing $3 billion in non-operating expense (9% of revenue). We removed $3 billion related to non-operating expenses and there were no adjustments related to non-operating income. See all adjustments made to AXP’s income statement here.

Balance Sheet: we made $7.1 billion of adjustments to calculate invested capital with a net increase of $3.8 billion. The most notable adjustment was $2.4 billion (7% of reported net assets) related to other comprehensive income. See all adjustments to AXP’s balance sheet here.

Valuation: we made $1.7 billion of adjustments with a net effect of decreasing shareholder value by $1.7 billion. There were no adjustments that increased shareholder value. The largest adjustment to shareholder value was $872 million in off-balance sheet operating leases. This lease adjustment represents 1% of AXP’s market value. Despite the decrease in shareholder value, AXP remains undervalued.

This article originally published on April 5, 2018.

Disclosure: David Trainer and Kyle Guske II receive no compensation to write about any specific stock, style, or theme.

Follow us on Twitter, Facebook, LinkedIn, and StockTwits for real-time alerts on all our research.

[1] Harvard Business School features the powerful impact of our research automation technology in the case New Constructs: Disrupting Fundamental Analysis with Robo-Analysts.

[2] Ernst & Young’s recent white paper “Getting ROIC Right” proves the superiority of our holdings research and analytics.

Article by Kyle Guske II, New Constructs


Saved Articles

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

What’s missing today for many investors is real, straightforward advice.

Especially when it comes to Value Investing and Hedge Funds. 💵

That’s what makes ValueWalk Premium different. Some would say we’re “unusual.”

Our subscribers look forward to clear, easy-to-understand information they can act on.

Sign up for  today for only a few dollars a day and get a 3 day no obligation trial with a targeted 20% discount coupon code.

Cancel anytime during trial and you are never charged.

Limited time offer: For first 50 subscribers